A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer

J. Randolph Hecht(UCLA Jonsson Comprehensive Cancer Center), Rafael G. Amado(Ghent University Hospital)

Journal of Clinical Oncology

December 30, 2008

10.1200/jco.2008.19.8135

Cited by 852

Related Papers

A randomized, double-blind, placebo-controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222584 or placebo (CONFIRM-1)

|Journal of Clinical Oncology|2005|201

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction

|British Journal of Cancer|2011|85